Affiliation:
1. University of Electronic Science and Technology of China
2. the Fourth People's Hospital of Zigong City
3. Affiliated Hospital of Southwest Medical University
Abstract
Abstract
Purpose: We were development and evaluation of one deep learning (DL) framework for identification of Peri-ampullary (PA) regions and diagnosis of peri-ampullary tumor (PAT) conditions in MRI images.
Experimental Design: We retrospectively analyzed 1,038 patients. We found that DL algorithm for identification of PA regions and diagnosis of PAT conditions in MRI images.
Results: The DL algorithm successfully identified and segmented the PA regions in both T1WI (IOU = 0·62) and T2WI images (IOU = 0·55). Based on the segmentations of PA regions in images, the classification DL algorithm achieved optimal accuracies in classifications of NPA and PSOL with AUC of 0·71 (95% CI 0·68 to 0·74) (T1WI) and 0·72 (95% CI 0·68 to 0·75) (T2WI). For PSOL cases, another classification DL algorithm achieved encouraging accuracies to further classify PAT and Non-PATL with AUC of 0·81 (95% CI 0·77 to 0·85) (T1WI) and 0·78 (95% CI 0·73 to 0·83) (T2WI). Furthermore, in the patient-based approach, the classification DL algorithm achieved optimal accuracies in classifications of NPA and PSOL with ACC of 0·75 (95% CI 0·65 to 0·85) (T1WI) and 0·88 (95% CI 0·81 to 0·94) (T2WI). For PSOL cases, another classification DL algorithm achieved encouraging accuracies to further classify PAT and Non-PATL with ACC of 0·83 (95% CI 0·71 to 0·96) (T1WI) and 0·82 (95% CI 0·70 to 0·93) (T2WI).
Conclusions: Our study suggests that DL could accurately identify and segment PA regions in MRI images and further classify PAT conditions with promising accuracies. DL could assist clinicians in MRI interpretation for PAT diagnosis.
Publisher
Research Square Platform LLC
Reference51 articles.
1. An audit of outcomes of a series of periampullary carcinomas;Berberat PO;Eur J Surg Oncol,2009
2. Influence of non-jaundice stage at diagnosis on clinicopathological features and long-term survival of patients with periampullary carcinomas;Peng X;Medicine (Baltimore),2019
3. Sarmiento, J.M., Nagomey Dm Fau - Sarr, M.G., Sarr Mg Fau - Farnell, M.B. & Farnell, M.B. (2002) Periampullary cancers: are there differences? Surg Clin North Am.
4. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients;Baghmar S;J Gastrointest Cancer,2019
5. Approach to the endoscopic resection of duodenal lesions;Gaspar JP;World J Gastroenterol,2016